Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Salt Lake City, UT, April 09, 2026 (GLOBE NEWSWIRE) -- TAP Real Estate (OTC: RWAX) is pleased to welcome Jeff Jarrard as Chief Technology Officer (CTO), where he will lead the buildout and...
-
China National Intellectual Property Administration has granted a patent covering potency assay methods for assessing human mesenchymal stem cells (MSCs).
-
Patent validates AI-powered platform for moving cost estimation and marketplace matching technology
-
Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204
-
NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications
-
The USPTO issued Xeriant (OTCQB: XERI) a Notice of Allowance covering its proprietary multilayered fire-resistant composite and method of making same.
-
MALVERN, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
-
Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204
-
Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist
-
Nasdaq Private Market receives U.S. patent for settlement engine for private company securities, a first for the private market industry